| 0 (0%) | 12-05 10:02 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 9.78 | 1-year : | 11.43 |
| Resists | First : | 8.38 | Second : | 9.78 |
| Pivot price | 7.17  |
|||
| Supports | First : | 6.97 | Second : | 6.09 |
| MAs | MA(5) : | 7.21 |
MA(20) : | 6.99 |
| MA(100) : | 6.69 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 58.3 |
D(3) : | 53.2 |
| RSI | RSI(14): 51.4 |
|||
| 52-week | High : | 15.47 | Low : | 3.75 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MYGN ] has closed below upper band by 42.2%. Bollinger Bands are 5.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.38 - 7.42 | 7.42 - 7.46 |
| Low: | 7.05 - 7.1 | 7.1 - 7.14 |
| Close: | 7.25 - 7.32 | 7.32 - 7.39 |
Wed, 03 Dec 2025
Why Is Myriad (MYGN) Up 8.7% Since Last Earnings Report? - sharewise.com
Wed, 03 Dec 2025
1 Healthcare Stock with Promising Prospects and 2 We Question - The Globe and Mail
Mon, 01 Dec 2025
Why Myriad Genetics (MYGN) Stock Is Trading Lower Today - Finviz
Sun, 30 Nov 2025
Myriad Genetics, Inc. $MYGN Stock Holdings Lifted by XTX Topco Ltd - MarketBeat
Wed, 19 Nov 2025
Why Myriad Genetics (MYGN) Stock Is Up Today - Yahoo Finance
Tue, 18 Nov 2025
Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 93 (M) |
| Shares Float | 86 (M) |
| Held by Insiders | 2.9 (%) |
| Held by Institutions | 97.9 (%) |
| Shares Short | 7,690 (K) |
| Shares Short P.Month | 7,760 (K) |
| EPS | -4.35 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4 |
| Profit Margin | -48.6 % |
| Operating Margin | -11.4 % |
| Return on Assets (ttm) | -5.7 % |
| Return on Equity (ttm) | -72.6 % |
| Qtrly Rev. Growth | -3.6 % |
| Gross Profit (p.s.) | 6.23 |
| Sales Per Share | 8.85 |
| EBITDA (p.s.) | -0.29 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | 10 (M) |
| PE Ratio | -1.69 |
| PEG Ratio | 0 |
| Price to Book value | 1.82 |
| Price to Sales | 0.82 |
| Price to Cash Flow | -309.72 |
| Dividend | 1.75 |
| Forward Dividend | 0 |
| Dividend Yield | 23.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|